U.S. Banks Stock News

NasdaqGM:HELP
NasdaqGM:HELPPharmaceuticals

Cybin (HELP) Is Up 19.8% After Deepening Psychedelic Pipeline And Leadership Shift Is The Risk Story Changing?

In August 2026, Cybin Inc. reported a first-quarter net loss of US$47.82 million, with basic and diluted loss per share from continuing operations of US$0.91, while Helus Pharma appointed experienced HR leader Regina Donohue as Chief People Officer and CNS drug-development expert Suresh Durgam, M.D., to its Scientific Advisory Board. Investor interest in Cybin has been influenced by its psychedelic medicine pipeline progress, including HLP003 entering a Phase 3 trial for major depressive...
NYSE:BFH
NYSE:BFHConsumer Finance

Is Bread Financial Holdings (BFH) Fully Valued On Its TestMu Conference Appearance?

Bread Financial Holdings (BFH) is set to present at the 5th TestMu Conference on August 19, 2026. Director of Engineering Rakesh Sukla will highlight the company’s platform and quality engineering approach for its payment and lending solutions. Bread Financial Holdings’ share price has climbed 19.7% over the past 90 days and 42.93% year to date, while its 1 year total shareholder return of 70.08% and 3 year total shareholder return of 199.48% point to strong momentum that this latest...
NasdaqGM:PSNY
NasdaqGM:PSNYAuto

Polestar (PSNY) Is Down 14.1% After US Orders Halt To Operations And Sales - What's Changed

Earlier in August 2026, Polestar Automotive Holding UK disclosed that the US Commerce Department had ordered it to halt all operations and vehicle sales in the United States, even as related brand Volvo Cars continued to serve the same market. This unexpected, company-specific restriction introduces fresh regulatory uncertainty for Polestar, potentially affecting how investors assess its access to key markets and execution risk. We’ll now examine how this forced halt to US operations could...
NYSE:ARES
NYSE:ARESCapital Markets

Ares Management (ARES) Could Be 2% Undervalued On Q2 Results And MedImpact Loan

Ares Management (ARES) is back in focus after its Jul. 31 Q2 report and a new role leading a US$2.2b direct loan for MedImpact Holding. Both developments give investors fresh data to reassess the stock. Ares Management’s recent Q2 report and the MedImpact loan mandate arrive after a mixed year for the stock. The share price is at US$142.76 and a 30 day share price return of 12.84% contrasts with a year to date share price decline of 14.17% and a 1 year total shareholder return decline of...
NasdaqCM:ALM
NasdaqCM:ALMMetals and Mining

Almonty Industries (ALM) Could Be 57% Below Fair Value Following 5% Buyback Plan

Almonty Industries (ALM) has announced a substantial share repurchase program, authorizing the buyback of up to 14,400,000 shares, or 5% of its issued share capital, for US$300 million through August 24, 2029. The buyback news arrives after a sharp shift in momentum for Almonty Industries, with the share price up 41.9% over the past 30 days and 115.11% year to date, even though the 90 day share price return declined 6.89%. Over the longer term, total shareholder return has been very large...
NYSE:AMP
NYSE:AMPCapital Markets

Higher For Longer Rates Make These U.S. Financial Stocks Worth A Closer Look

With U.S. public debt near 100% of GDP and long-term yields reflecting that strain, higher for longer rates are reshaping how capital is priced and where returns might come from. That shift can pressure some stocks yet create fresh openings for others tied to lending and investment income. This article walks through three large-cap financial stocks exposed to this rate story and why they may warrant a closer look now. The three stocks covered below are just a sample, and the full screen...
NasdaqGS:ACLS
NasdaqGS:ACLSSemiconductor

Do Elevated Put Volatility and Higher Earnings Forecasts Reveal a Turning Point in Axcelis (ACLS)?

Recently, Axcelis Technologies saw elevated activity in its options market, with the September 18, 2026 $50 put showing especially high implied volatility, pointing to expectations of a significant move in the stock. At the same time, several analysts have lifted their earnings estimates for Axcelis, suggesting that the options activity is anchored in improving fundamental expectations rather than purely technical trading. Next, we’ll examine how this combination of heightened put-option...
NasdaqGS:ERIE
NasdaqGS:ERIEInsurance

Erie Indemnity (ERIE) Rebounds, But Is The Valuation Already Full?

Erie Indemnity (ERIE) has drawn investor attention after its recent share price move, with the stock closing at US$257.98. This follows a mixed performance across recent periods, including the past month and the past three months. Over the past year, Erie Indemnity has seen its share price momentum fade, with a year to date share price decline of 7.14% and a 1 year total shareholder return down 24.75%, even after a stronger 30 day share price return of 15.40% and a 90 day gain of 16.89% that...
NYSE:DD
NYSE:DDIndustrials

DuPont (DD) Stock May Trade At A Discount On Cash Flow

DuPont de Nemours stock has delivered a 60.6% total return over the past five years, while current valuation checks send a mixed message as the intrinsic value estimate suggests upside compared with a richer read from market multiples. The Discounted Cash Flow (DCF) work points to the shares trading at about a 30.5% discount to intrinsic value, yet earnings based multiples screen the stock as overvalued. A 60.6% return over five years places DuPont de Nemours in solid long term territory,...
NasdaqGS:ULTA
NasdaqGS:ULTASpecialty Retail

Ulta Beauty (ULTA) Broadens Prestige Hair Care With New Exclusive Partnerships

Ulta Beauty (NasdaqGS:ULTA) is expanding its prestige hair care lineup with new exclusive partnerships, including The Potion Studio and Bio Ionic. The Potion Studio is launching its climate adaptive hair care line at Ulta Beauty, headlined by the exclusive Control Potion Styling Gel with a focus on textured hair. Bio Ionic is introducing a limited edition Jade Dream Collection of professional grade styling tools available only at Ulta Beauty. The new exclusives widen Ulta Beauty's prestige...
NYSE:NOW
NYSE:NOWSoftware

ServiceNow (NOW) Brings AI Deal Optimization Into Sales Workflows

ServiceNow (NYSE: NOW) and pricing software provider Pricefx announced a new integration that brings AI-powered deal optimization into ServiceNow sales workflows. The integration embeds pricing intelligence and real-time negotiation tools directly into ServiceNow for manufacturers and complex B2B organizations. The move extends ServiceNow's applied AI capabilities into commercial pricing execution and governance for enterprise clients. This kind of applied AI inside core business workflows...
NasdaqGS:QBTS
NasdaqGS:QBTSSoftware

How Investors May Respond To D-Wave Quantum (QBTS) CFO Transition To Internal Finance Leader

D-Wave Quantum Inc. announced that long-time CFO John Markovich retired on September 2, 2026, with senior vice president of finance Greg Golkov stepping in as acting Chief Financial Officer and principal financial and accounting officer. The move places day-to-day financial leadership in the hands of an internal executive with extensive public-company reporting and controls experience, potentially affecting how D-Wave manages capital, disclosure, and its path toward profitability. We’ll now...
NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

Semtech (SMTC) Stock Looks Strong After A 3 Year Run Yet Rich On Sales

Semtech stock has posted very strong returns in recent years, yet current valuation checks lean expensive and suggest the recent share price strength may already reflect a lot of good news. Over the past 3 years, Semtech has delivered a very large gain of about 3.9x, which puts extra focus on whether the current price leaves much room for error. New LoRa Plus transceivers and the planned sale of the cellular module business can support expectations for a more focused Semtech. At the same...
NYSE:PH
NYSE:PHMachinery

Does Parker Hannifin (PH) Look Overvalued After Its Filtration Deal?

Parker-Hannifin stock has delivered a very strong 5 year run, yet the latest valuation checks suggest the shares now trade close to what current models view as fair value rather than as a clear bargain. The share price has gained about 264.1% over 5 years, which puts extra focus on whether recent returns already reflect the company’s long term cash flow potential. The completed acquisition of Filtration Group Corporation may support longer term revenue and earnings power. The risk is that...
NasdaqGS:AFRM
NasdaqGS:AFRMDiversified Financial

Affirm (AFRM) Is Up 6.0% After First GAAP Profit And Card Growth Milestone - What's Changed

Earlier this week, Affirm Holdings highlighted rapid expansion in its card business, first-time GAAP operating profitability as a public company, and upcoming earnings in which analysts expect year-on-year revenue growth of 26.4% to about US$1.11 billion. Analysts and investors are increasingly focused on whether Affirm’s fast-growing card segment can become a second engine alongside its core buy now, pay later network. Now we’ll examine how Affirm’s accelerating card adoption and first GAAP...
NYSE:LNG
NYSE:LNGOil and Gas

Cheniere Energy Stock And 2 Oil And Gas Shares For LNG Supply Disruption

A collapsing Iranian rial, war risk tied to US and Israel actions, and rising hazards around the Strait of Hormuz are reshaping how investors think about global energy supply and pricing power. These shocks can reward some companies and challenge others. This article walks through three large integrated oil and gas stocks from our screener that are closely linked to this story and explains why their exposure to the news may matter to your portfolio. The three companies profiled below are only...
NasdaqGS:SAFT
NasdaqGS:SAFTInsurance

Safety Insurance Group (SAFT) Stock Looks Overvalued After A 71% Run

Safety Insurance Group stock has delivered a strong 71.4% return over the past three years, while the latest valuation checks suggest investors are paying a premium relative to an intrinsic value estimate based on excess returns. With both the Excess Returns model and market multiples pointing in the same direction, the stock looks priced more for optimism than for obvious value. The 71.4% three year gain highlights how much future expectations are already reflected in Safety Insurance...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

CVB Financial (CVBF) Gets A Zacks Upgrade, Is An 11% Discount Still Justified?

CVB Financial (CVBF) drew fresh attention after Zacks upgraded the stock to a Rank #2, based on an upward trend in earnings estimates over the past three months. At a share price of $22.39, CVB Financial has slipped over the past week with a 7 day share price return of 2.82% and is slightly down over the past month, yet the 90 day share price return of 9.27% and year to date share price return of 19.93% point to building momentum. The 1 year total shareholder return of 15.06% and 3 year total...
NYSE:ELAN
NYSE:ELANPharmaceuticals

Is Elanco (ELAN) Quietly Reframing Its Pet Therapeutics Strategy With This Kansas Antibody Expansion?

Elanco Animal Health has completed a 25,000-square-foot, US$120 million manufacturing expansion at its Elwood, Kansas site, quadrupling monoclonal antibody capacity and adding a pilot plant, new quality control lab and support spaces, with a further US$30 million warehousing investment planned through 2028. This enlarged facility underpins production of Elanco’s new monoclonal antibody treatments Befrena and Trutect, reinforcing its push into advanced pet therapeutics as pet owners demand...
NasdaqGS:TXG
NasdaqGS:TXGLife Sciences

10x Genomics (TXG) Could Be 31% Above Fair Value After Its Sharp Rally

10x Genomics (TXG) has drawn investor attention after recent share price gains over the past month and past 3 months. The stock closed at $64.72 on 26 August 2026, with recent returns significantly higher than its 1-year figure. For you as an investor, the recent momentum in 10x Genomics is hard to ignore. The 30 day share price return is 39.87% and the 90 day share price return is 153.70%, while the 1 year total shareholder return of 361.30% contrasts with a 5 year total shareholder return...
OTCPK:LKNC.Y
OTCPK:LKNC.YHospitality

Luckin Coffee (OTCPK:LKNC.Y) Stock Trades At A Discount On Cash Flow And Earnings

Luckin Coffee stock has produced strong long term gains over the past five years, while current valuation checks suggest the shares may still trade below an estimate of intrinsic value. For investors, the key issue is how much confidence to place in that apparent discount. Over five years, Luckin Coffee has returned 172.2%, which puts the recent share price in the context of a meaningful longer run gain already on the table. The main potential support for valuation is the company’s ability...
NYSE:APD
NYSE:APDChemicals

Eaton Stock And 2 Global Industrials Tied To A Weaker Dollar

When Fed Chair Kevin Warsh steps up in Jackson Hole with inflation still at 3.7% and long term yields in focus, the stakes for global exporters and commodity producers rise sharply. Potential dollar weakness or strength could reshape where returns come from next, especially for companies earning abroad. This article walks through three stocks exposed to that macro crosswind and explains how each might fit, or might not fit, in your portfolio plan. The three stocks below are only a starting...